The poster presentation schedule will be available on the Symposium website no later than Friday, July 25. Presenters need to be available for public discussion of your research during one of the ...

MAIA Biotechnology, Inc.,, a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced that an abstract about its Phase 2 THIO-101 clinical trial ...